10-Nov-2025
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
TipRanks (Fri, 7-Nov 7:27 AM ET)
Addus HomeCare to Participate in Upcoming Investor Conferences in November
Business Wire (Wed, 5-Nov 11:00 AM ET)
Addus HomeCare Announces Third Quarter 2025 Financial Results
Business Wire (Mon, 3-Nov 4:05 PM ET)
Addus HomeCare Announces Third Quarter 2025 Earnings Release and Conference Call
Business Wire (Mon, 20-Oct 11:00 AM ET)
Addus HomeCare to Participate in the Jefferies 2025 Healthcare Services Conference
Business Wire (Tue, 23-Sep 11:00 AM ET)
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
Addus Homecare trades on the NASDAQ stock market under the symbol ADUS.
As of November 10, 2025, ADUS stock price declined to $112.83 with 155,683 million shares trading.
ADUS has a beta of 0.24, meaning it tends to be less sensitive to market movements. ADUS has a correlation of 0.02 to the broad based SPY ETF.
ADUS has a market cap of $2.08 billion. This is considered a Mid Cap stock.
Last quarter Addus Homecare reported $362 million in Revenue and $1.56 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.10.
In the last 3 years, ADUS traded as high as $136.72 and as low as $77.30.
The top ETF exchange traded funds that ADUS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
ADUS has underperformed the market in the last year with a price return of -11.6% while the SPY ETF gained +15.1%. ADUS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.4% and -7.1%, respectively, while the SPY returned +7.2% and -0.6%, respectively.
ADUS support price is $110.32 and resistance is $115.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADUS shares will trade within this expected range on the day.